Enzymatic Synthesis of Peptide Nanofibers for Self-Delivery of Indomethacin and Tyroservatide in Cancer Therapy
- 9 June 2022
- journal article
- research article
- Published by American Chemical Society (ACS) in ACS Biomaterials Science & Engineering
- Vol. 8 (7) , 3010-3021
Abstract
Non-steroidal anti-inflammatory drugs (NSAIDs) have drawn considerable attention in the field of cancer treatment, yet these drugs display limited potency and selectivity against cancer cells. To address these problems, we designed a peptide-based self-delivery system [Indomethacin-Phe-Phe-Tyr (H2PO3)-Ser-Val, IDM-FFpYSV] that combines an NSAID molecule (indomethacin, or IDM) and a segment of anticancer tripeptide (tyroservatide, or YSV). IDM-FFpYSV is capable of self-assembling in an aqueous solution to afford nanofibrillar hydrogels under the catalysis of alkaline phosphatases (ALPs), which are overexpressed on the plasma membrane of cancer cells. The IDM-FFpYSV + ALP hydrogel displays a continuous release profile of peptide drugs, whereas a solution mixture of pure drugs (IDM-OH + pYSV + ALP) shows burst release of drug moieties. The treatment of IDM-FFpYSV selectively inhibits the proliferation of HeLa cells in vitro, with precise regulations of intracellular targeting proteins (COX-2 and AC-H3). The enhanced potency and selectivity of IDM-FFpYSV are found to be attributed to enhanced cellular uptake of peptide drugs, which involves a caveolae-mediated endocytosis pathway. Furthermore, intravenous administration of the IDM-FFpYSV formulation significantly inhibits the tumor growth in a HeLa-xenografted mouse model, whereas treatment of solution mixtures of pure drugs (IDM-OH + pYSV) fails to do so. Taken together, the study provides a viable strategy to augment anticancer efficacies of self-delivery system through molecular integration of multiple anticancer elements with an enzyme-instructed self-assembly process.Keywords
Funding Information
- China Pharmaceutical University (CPU 2018GY25)
- Natural Science Foundation of Jiangsu Province (BK20191326)
- National Natural Science Foundation of China (21775165, 21877128, 51973234)
This publication has 36 references indexed in Scilit:
- Drug self-delivery systems for cancer therapyBiomaterials, 2017
- COX-2 inhibitors: a novel strategy in the management of breast cancerDrug Discovery Today, 2016
- Molecular Pathways: Aspirin and Wnt Signaling—A Molecularly Targeted Approach to Cancer Prevention and TreatmentClinical Cancer Research, 2015
- Aspirin, NSAIDs, and Risk of Prostate Cancer: Results from the REDUCE StudyClinical Cancer Research, 2015
- Vascular and upper gastrointestinal effects of non-steroidal anti-inflammatory drugs: meta-analyses of individual participant data from randomised trialsThe Lancet, 2013
- Non-Steroidal Anti-Inflammatory Drugs and Colorectal Cancer Risk in a Large, Prospective CohortAmerican Journal of Gastroenterology, 2011
- Non-steroidal anti-inflammatory drugs to potentiate chemotherapy effects: From lab to clinicCritical Reviews in Oncology/Hematology, 2007
- Nonsteroidal Anti-Inflammatory Drugs, Alone or Combined With Opioids, for Cancer PainJournal of Clinical Oncology, 2004
- Nonsteroidal Anti-inflammatory Drugs as Anticancer Agents: Mechanistic, Pharmacologic, and Clinical IssuesJNCI: Journal of the National Cancer Institute, 2002
- Cyclooxygenases: Structural, Cellular, and Molecular BiologyAnnual Review of Biochemistry, 2000